Zimmer Partners, LP Q3 2020 Filing

Filed November 16, 2020

Portfolio Value

$6.5B

Holdings

117

Report Date

Q3 2020

Filing Type

13F-HR

All Holdings (117 positions)

#StockSharesValue% PortfolioType
101
ALLOVIR INC
25,000$688.0M10.64%
102
RLAYRELAY THERAPEUTICS INC
16,000$681.0M10.53%
103
PLYMPLYMOUTH INDL REIT INC
50,000$617.0M9.54%
104
AMWLAMERICAN WELL CORP
20,000$593.0M9.17%
105
TSHATAYSHA GENE THERAPIES INC
20,000$448.0M6.93%
106
SUMO2EURSUMO LOGIC INC
20,000$436.0M6.74%
107
KYMRKYMERA THERAPEUTICS INC
12,500$404.0M6.25%
108
BLIUSDBERKELEY LTS INC
5,000$382.0M5.91%
109
ALXOALX ONCOLOGY HLDGS INC
10,000$377.0M5.83%
110
ATHIRA PHARMA INC
20,000$369.0M5.71%
111
CMPSCOMPASS PATHWAYS PLC
10,000$349.0M5.40%
112
AFIBACUTUS MED INC
10,000$298.0M4.61%
113
CHECKMATE PHARMACEUTICALS IN
25,000$288.0M4.46%
114
VITLVITAL FARMS INC
7,000$284.0M4.39%
115
INZYINOZYME PHARMA INC
10,000$263.0M4.07%
116
DYNDYNE THERAPEUTICS INC
10,000$202.0M3.12%
117
PSTXUSDPOSEIDA THERAPEUTICS INC
11,000$98.0M1.52%
PreviousPage 2 of 2